# Studies addressing potential bioactivation and genotoxicity liabilities of the N-nitroso derivative of the antidepressant paroxetine-Pub

**URL:** <https://knowledgeexchange.usp.org/t/studies-addressing-potential-bioactivation-and-genotoxicity-liabilities-of-the-n-nitroso-derivative-of-the-antidepressant-paroxetine-pub/11772>\
**Category:** Chemistry\
**Tags:** NDSRI\
**Created:** [November 18, 2025, 4:21pm UTC](https://knowledgeexchange.usp.org/t/studies-addressing-potential-bioactivation-and-genotoxicity-liabilities-of-the-n-nitroso-derivative-of-the-antidepressant-paroxetine-pub/11772 "2025-11-18T16:21:19Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![Yosukemino2](https://sea3.discourse-cdn.com/usp/user_avatar/knowledgeexchange.usp.org/yosukemino2/32/4246_2.png) [@Yosukemino2](https://knowledgeexchange.usp.org/u/Yosukemino2)\
**Post date:** [November 18, 2025, 4:21pm UTC](https://knowledgeexchange.usp.org/t/studies-addressing-potential-bioactivation-and-genotoxicity-liabilities-of-the-n-nitroso-derivative-of-the-antidepressant-paroxetine-pub/11772/1 "2025-11-18T16:21:19Z")

</div>

> **[Studies addressing potential bioactivation and genotoxicity liabilities of...](https://pubmed.ncbi.nlm.nih.gov/41196116/)**
>
> The mutagenicity and bioactivation potential of N-nitrosoparoxetine, a N-nitrosamine drug substance related impurity (NDSRI) of the marketed antidepressant paroxetine, was characterised in vitro.N-Nitrosoparoxetine was not mutagenic in an OECD...

## Abstract

The mutagenicity and bioactivation potential of _N_-nitrosoparoxetine, a _N_-nitrosamine drug substance related impurity (NDSRI) of the marketed antidepressant paroxetine, was characterised _in vitro_._N_-Nitrosoparoxetine was not mutagenic in an OECD 471-compliant bacterial reverse mutation assay even under experimental conditions that supported oxidative metabolism by CYP enzymes. The major biotransformation pathways of _N_-nitrosoparoxetine paralleled the ones previously noted with paroxetine. Virtually all stable metabolites of _N_-nitrosoparoxetine in human, rat, and hamster liver tissue were derived from phase 2 conjugations on an unstable catechol intermediate, generated from the oxidative 1,3-benzodioxole ring scission by CYP enzymes. The piperidine ring in _N_-nitrosoparoxetine was resistant to the α-carbon oxidation step leading to piperidine ring scission, and to the eventual formation of a DNA-reactive electrophilic species.CYP reaction phenotyping studies demonstrated that paroxetine was exclusively metabolised by human CYP2D6, whereas _N_-nitrosoparoxetine was subject to metabolism by multiple human CYP isoforms including CYP2C19, CYP2D6, and CYP3A4.Whether most NDSRIs derived from parent amine precursors that are resistant to α-carbon oxidation by CYPs will also be devoid of a mutagenic response _in vitro_ needs to be scrutinised further with additional examples to bolster structure-genotoxicity relationships of complex NDSRIs.
